<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="173">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on March 04, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04529915</url>
  </required_header>
  <id_info>
    <org_study_id>2020GR0176</org_study_id>
    <nct_id>NCT04529915</nct_id>
  </id_info>
  <brief_title>Multicenter Clinical Research for Early Diagnosis of Lung Cancer Using Blood Plasma Derived Exosome</brief_title>
  <official_title>Multicenter Clinical Research for Early Diagnosis of Lung Cancer Using Blood Plasma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Korea University Guro Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Korea University Guro Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lung cancer is a leading cause of cancer death worldwide. Early diagnosis is linked to a&#xD;
      better prognosis. Further, surgical resection at the early stages of non-small cell lung&#xD;
      cancer (NSCLC) results in markedly improved survival rates. Computed tomography (CT)- or&#xD;
      bronchoscopy-guided needle biopsies are standard definitive diagnostic procedures for lung&#xD;
      cancer and are used to obtain tissue for pathological examination. However, these procedures&#xD;
      are invasive, difficult to repeat, expensive, and risk exposure to radiation. Conversely,&#xD;
      liquid biopsies, such as circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and&#xD;
      extracellular vesicles (EVs), are simple and less invasive procedures that can be repeated&#xD;
      more frequently than tissue biopsies.&#xD;
&#xD;
      To analyze the exosomes abundantly present in the blood and to conduct clinical studies to&#xD;
      determine whether it is possible to diagnose lung cancer. To this end, blood samples from&#xD;
      normal people (n = 150) and lung cancer patients (n = 320) are obtained from the Human&#xD;
      biobank of five hospitals participating in the study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 9, 2020</start_date>
  <completion_date type="Anticipated">December 29, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 29, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the distinction between healthy controls and lung cancer patients through deep-learning analysis of exosomes</measure>
    <time_frame>3 years</time_frame>
    <description>Comparative evaluation of whether it is possible to distinguish between healthy controls and lung cancer patients through deep-learning analysis of exosomes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluating the possibility of distinguishing between normal and lung cancer patients through the analysis of lung cancer-specific exosomal protein</measure>
    <time_frame>3 years</time_frame>
    <description>Quantitative analysis using lung cancer-specific exosomal protein evaluated the possibility of distinguishing between healthy controls and lung cancer patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the possibility of distinguishing the early pathological stages in lung cancer patients through deep-learning analysis of exosomes</measure>
    <time_frame>3 years</time_frame>
    <description>Evaluating whether the early stages of lung cancer patients can be distinguished using deep-learning analysis of exosomes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the possibility of distinguishing the early pathological stages in lung cancer patients through quantitative analysis of lung cancer specific exosomal proteins</measure>
    <time_frame>3 years</time_frame>
    <description>Evaluating whether the early stages of lung cancer patients can be distinguished using quantitative analysis of lung cancer specific exosomal proteins</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">470</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Lung cancer</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Exosome sampling</intervention_name>
    <description>Centrifugation of blood plasma&#xD;
Size exclusion chromatography&#xD;
ELISA assay, Western blotting&#xD;
Deep-learning analysis</description>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>Lung cancer</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood plasma&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        For this study, Koreans, regardless of gender, were studied for adults over 40 years of&#xD;
        age.&#xD;
&#xD;
        Participating institutions for this clinical research are Korea University Guro Hospital,&#xD;
        Gangnam Severance Hospital, Bundang Seoul National University Hospital, Seoul Asan&#xD;
        Hospital, and Samsung Seoul Hospital.&#xD;
&#xD;
        Blood plasma samples is taken from stored in the biobank of each hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with primary adenocarcinoma of lung with permanent pathology of N0 or N1&#xD;
&#xD;
          2. Patients with T1mi, Tsi, T1a, T1b, T1c, T2a, and T2b stage&#xD;
&#xD;
          3. An adult of Korean nationality&#xD;
&#xD;
          4. Patients without prior chemo/radiation treatment prior to lung cancer surgery&#xD;
&#xD;
          5. Patients who have not been diagnosed with other cancers prior to lung cancer surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who do not meet the inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyun Koo MD, PhD, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Korea University Guro Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Guro-gu</state>
        <zip>08308</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Kaplan RN, Rafii S, Lyden D. Preparing the &quot;soil&quot;: the premetastatic niche. Cancer Res. 2006 Dec 1;66(23):11089-93. Review.</citation>
    <PMID>17145848</PMID>
  </reference>
  <reference>
    <citation>Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer. 2009 Apr;9(4):285-93. doi: 10.1038/nrc2621. Review.</citation>
    <PMID>19308068</PMID>
  </reference>
  <reference>
    <citation>Talmadge JE, Fidler IJ. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res. 2010 Jul 15;70(14):5649-69. doi: 10.1158/0008-5472.CAN-10-1040. Epub 2010 Jul 7. Review.</citation>
    <PMID>20610625</PMID>
  </reference>
  <reference>
    <citation>Bidard FC, Pierga JY, Vincent-Salomon A, Poupon MF. A &quot;class action&quot; against the microenvironment: do cancer cells cooperate in metastasis? Cancer Metastasis Rev. 2008 Mar;27(1):5-10. Review.</citation>
    <PMID>18066649</PMID>
  </reference>
  <reference>
    <citation>van Akkooi AC, Verhoef C, Eggermont AM. Importance of tumor load in the sentinel node in melanoma: clinical dilemmas. Nat Rev Clin Oncol. 2010 Aug;7(8):446-54. doi: 10.1038/nrclinonc.2010.100. Epub 2010 Jun 22. Review.</citation>
    <PMID>20567244</PMID>
  </reference>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>August 2, 2020</study_first_submitted>
  <study_first_submitted_qc>August 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2020</study_first_posted>
  <last_update_submitted>December 10, 2021</last_update_submitted>
  <last_update_submitted_qc>December 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Korea University Guro Hospital</investigator_affiliation>
    <investigator_full_name>Hyun Koo Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Blood plasma</keyword>
  <keyword>Exosome</keyword>
  <keyword>Liquid biopsy</keyword>
  <keyword>Lung cancer</keyword>
  <keyword>Biomarker</keyword>
  <keyword>Deep-learning analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

